Edition:
United Kingdom

Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

96.88EUR
10:45am GMT
Change (% chg)

€-0.20 (-0.21%)
Prev Close
€97.08
Open
€96.68
Day's High
€98.00
Day's Low
€96.50
Volume
137,281
Avg. Vol
557,528
52-wk High
€99.40
52-wk Low
€74.54

Chart for

About

Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company operates through four business segments: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnol... (more)

Overall

Beta: 1.01
Market Cap(Mil.): €12,352.97
Shares Outstanding(Mil.): 129.24
Dividend: 1.20
Yield (%): 1.26

Financials

  MRCG.DE Industry Sector
P/E (TTM): 24.91 31.23 33.60
EPS (TTM): 3.84 -- --
ROI: 5.93 15.57 15.05
ROE: 12.78 16.94 16.62

Palantir to offer cancer analytics under JV deal with Germany's Merck

((This NOV 19 story corrects to show Merck is Palantir's exclusive partner within the JV, not for all of Palantir's healthcare activities, paragraph 11))

20 Nov 2018

CORRECTED-UPDATE 1-Palantir to offer cancer analytics under JV deal with Germany's Merck

FRANKFURT, Nov 19 Palantir Technologies Inc will set up a cancer data analytics joint venture with German lab supplies company Merck KGaA, as the U.S. analytics and security firm makes further inroads into health care.

20 Nov 2018

Palantir to offer cancer analytics under JV deal with Germany's Merck

FRANKFURT, Nov 19 Palantir Technologies Inc will set up an exclusive cancer research joint venture with German lab supplies company Merck KGaA, as the U.S. data analytics and security firm makes further inroads into health care.

19 Nov 2018

Merck KGaA third-quarter earnings down on weak Latam currencies

FRANKFURT German drugs and lab supplies maker Merck KGaA saw adjusted core earnings decline and lowered its full-year profit outlook as a decline in Latin American currencies weighed on the value of overseas sales.

14 Nov 2018

Merck KGaA Q3 earnings down on weak Latam currencies

FRANKFURT, Nov 14 German drugs and lab supplies maker Merck KGaA saw adjusted core earnings decline and lowered its full-year profit outlook as a decline in Latin American currencies weighed on the value of overseas sales.

14 Nov 2018

German stocks - Factors to watch on Oct. 22

FRANKFURT/BERLIN, Oct 22 - The following are some of the factors that may move German stocks on Monday:

22 Oct 2018

Merck KGaA says might strike partnership deal this year

MUNICH German drugmaker Merck KGaA might agree partnership deals to jointly develop two of its most promising experimental medicines with a rival as early as this year, but more likely in 2019, its drug research and development chief said on Sunday.

21 Oct 2018

Merck KGaA says might strike partnership deal this year

MUNICH, Oct 21 German drugmaker Merck KGaA might agree partnership deals to jointly develop two of its most promising experimental medicines with a rival as early as this year, but more likely in 2019, its drug research and development chief said on Sunday.

21 Oct 2018

EU mergers and takeovers (Aug 28)

BRUSSELS, Aug 28 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

28 Aug 2018

EU clears 3.4 billion euro P&G deal for German Merck's consumer health business unit

BRUSSELS EU antitrust regulators have approved Procter & Gamble's (P&G) 3.4 billion euro (£3.08 billion) acquisition of Merck KGaA's consumer health unit, saying on Tuesday that they had no competition concerns.

28 Aug 2018

Earnings vs. Estimates